Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.
about
Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individualsAging and the environment: a research frameworkDetermination of no-observed effect level (NOEL)-biomarker equivalents to interpret biomonitoring data for organophosphorus pesticides in childrenGender and manganese exposure interactions on mouse striatal neuron morphologyHuman milk biomonitoring data: interpretation and risk assessment issues.The acquisition and application of absorption, distribution, metabolism, and excretion (ADME) data in agricultural chemical safety assessments.Incorporation of pharmacokinetic and pharmacodynamic data into risk assessments.An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants.Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents.Computational pharmacokinetics during developmental windows of susceptibility.Addressing Early Life Sensitivity Using Physiologically Based Pharmacokinetic Modeling and In Vitro to In Vivo Extrapolation.Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects?Approaches for applications of physiologically based pharmacokinetic models in risk assessment.Characterization of the human kinetic adjustment factor for the health risk assessment of environmental contaminants.Gender-specific differences in the central nervous system's response to anesthesia.Role of the cytochrome P450 enzyme system in veterinary pharmacokinetics: where are we now? Where are we going?Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences.Sex Differences in Human and Animal Toxicology.Age-specific absolute and relative organ weight distributions for Fischer 344 rats.Evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.Age-specific absolute and relative organ weight distributions for B6C3F1 mice.Guidance on the risk assessment of substances present in food intended for infants below 16 weeks of ageChemical partitioning of fine particle-bound As, Cd, Cr, Ni, Co, Pb and assessment of associated cancer risk due to inhalation, ingestion and dermal exposure.Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.Assessing the impact of the duration and intensity of inhalation exposure on the magnitude of the variability of internal dose metrics in children and adults
P2860
Q24815657-B8D3EDFA-663D-4D23-A6EB-77F143E3721FQ24815677-F098EDDB-422C-4174-850D-8EEC39ADFDF2Q28387646-2512EE74-6628-4385-A1F6-F07E57EA227EQ28391734-95040F14-1F57-4C6D-B433-5F5681102D7DQ31006357-F25DBF3F-73F7-4A2E-A1D7-B4A7A04EECDAQ31041215-B5A5474D-4229-4957-8F68-AD3837CA036FQ33519666-BC85BA76-F09D-4300-A44F-F4DCE22CAA2EQ34374608-AF019EE7-64DD-435C-A066-619762951255Q35624622-D5EF025E-BF31-4E7C-9F5D-AB24B47290F4Q36195215-09374E66-2199-45B9-A4B9-E6FED87FE0C1Q36657666-3119BCCE-1439-45E6-A5BE-030A7DC4749FQ37004073-2B77C270-5822-4C81-87F5-1470E464CAC0Q37201545-E8333172-5B2D-4016-89E2-29E756A64F12Q38137867-E2AE9042-618A-428F-9716-C51AC60D3AEDQ38170002-07838D17-057C-4308-9338-41B12C4AFD6DQ39742342-58ACB02D-432F-4817-A49D-EB545ECAC7A3Q40148266-0DC6CBAF-140C-4A05-9362-BC1B7AD8343EQ40452643-199C3C0B-FE65-43E6-AC1A-34BFDD3C97CCQ43755705-E642C385-79BC-44B8-97B0-EA186691C3FFQ44824434-8D65C508-64A7-4BAB-A500-533860E12465Q46683945-E2228655-66C4-489C-8862-285BA33C7264Q47159532-CA750055-24A8-4888-BCEF-BA90FCA87C37Q47774703-E7BEC89B-551B-41BB-83BF-39952E507491Q53399970-9FF2E171-3E5E-408F-B87E-3FCC14F16439Q58402056-F56A284C-D822-4083-8EAE-C3093E4C7780
P2860
Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry.
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Review and evaluation of the p ...... fferences on tissue dosimetry.
@ast
Review and evaluation of the p ...... fferences on tissue dosimetry.
@en
Review and evaluation of the p ...... fferences on tissue dosimetry.
@nl
type
label
Review and evaluation of the p ...... fferences on tissue dosimetry.
@ast
Review and evaluation of the p ...... fferences on tissue dosimetry.
@en
Review and evaluation of the p ...... fferences on tissue dosimetry.
@nl
prefLabel
Review and evaluation of the p ...... fferences on tissue dosimetry.
@ast
Review and evaluation of the p ...... fferences on tissue dosimetry.
@en
Review and evaluation of the p ...... fferences on tissue dosimetry.
@nl
P2093
P2860
P356
P1476
Review and evaluation of the p ...... fferences on tissue dosimetry.
@en
P2093
Annette Shipp
Greg Lawrence
Harvey J Clewell
Justin Teeguarden
Ramesh Sarangapani
Robinan Gentry
Tammie Covington
Tracy McDonald
P2860
P304
P356
10.1080/20024091064264
P407
P577
2002-09-01T00:00:00Z